DNA Methylation and Developmental Genes in Lymphomagenesis—More Questions Than Answers?

Leukemia and Lymphoma

Volumn 24, Issue 42067, 1997, Pages 211-220

  Kay, Peter H ^a   Spagnolo, Dominic V ^a   Taylor, Jeremy ^a   Ziman, Melanie ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

developmental genes; leukemia; lymphoma; methylation

Indexed keywords

CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DEVELOPMENTAL GENETICS; DNA METHYLATION; EMBRYO DEVELOPMENT; GENE MUTATION; HUMAN; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MUSCLE DEVELOPMENT; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SILENCER GENE; TUMOR GROWTH;

ANIMALS; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; DNA-BINDING PROTEINS; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; HUMANS; LEUKEMIA, EXPERIMENTAL; LYMPHOMA; MICE; MICE, INBRED AKR; MYOD PROTEIN; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PAIRED BOX TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 0031058666     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709039009     Document Type: Article

References (58)

1. Holliday R., Pugh J. E. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226 – 232
2. Monk M. Methylation and the X-chromosome. Bioessays 1986; 4: 204 – 208
3. Holliday R. DNA Methylation: Molecular Biology and Biological Significance. Birkhauser Verlag, Basel 1992
4. Clark S. J., Harrison J., Frommer M. CpNpG methylation in mammalian cells. Nature Genet. 1995; 10: 20 – 27
5. Riggs A. D., Jones P. A. 5-methylcytosine. gene regulation and cancer. Adv. Cancer Rex 1983; 40: 1 – 30
6. Bird A., Taggart M., Frommer M., Miller O. J., McLeod D. A fraction of the mouse genorrie that is derived from islands of non-methylated CpG-rich DNA. Cell 1985; 40: 91 – 99
7. Naveh-Many T., Cedar H. Active gene sequences are undermethylated. Proc. Natl. Acad. Sci. (USA). 1981; 78: 4246 – 4250
8. Gardiner-Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Bid. 1987; 196: 261 – 282
9. Duncan B. K., Miller J. H. Mutagenic deamination of cytosine residues in DNA. Nature 1980; 287: 560 – 561
10. Bestor T. H., Ingram V. M. Two methyltransferases from murk erythroleukemia cells: purification, sequence specificity and mode of action with DNA. Proc. Natl. Acad. Sci. (USA) 1983; 80: 5559 – 5563
11. Yen R. W. C., Vertino P. M., Nelkin B. D., Yu J. J., El-Deiry W., Cumaraswamy A., Lennon G. G., Trask B. J., Celano P., Baylin S. J. Isolation and characterisation of the cDNA encoding human DNA methyltransferase. Nucl. Acids Res. 1992; 20: 2287 – 2291
12. Bestor T., Laudano A., Mattaliano R., Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J. Mol. Bid. 1988; 203: 971 – 983
13. Jost J. P. Nuclear extracts of chicken embryos promote an active demethylation of DNA by excision repair of 5-methyldeoxycytidine. Proc. Natl. Acad. Sci. (USA). 1993; 90: 46844688
14. Paroush Z., Keshet I., Yisraeli J., Cedar H. Dynamics of demethylation and activation of the α-actin gene in myoblasts. Cell 1990; 63: 1229 – 1237
15. Holliday R. The inheritance of epigenetic defects. Science 1987; 238: 163 – 170
16. Keshet I., Yisraeli J., Cedar H. Effect of regional DNA methylation on gene expression. Proc. Natl. Acad. Sci. (USA). 1985; 82: 2560 – 2564
17. Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362 – 365
18. Monk M., Boabelik M., Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 1987; 99: 371 – 382
19. Meehan R. R., Lewis J. D., McKay S., Kleiner E. L., Bird A. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989; 58: 499 – 507
20. Ehrlich M., Ehrlich K. C. DNA Methylation. Molecular Biology and Biological Significance. Birkhauser Verlag, Base 1993
21. Taylor S. M., Jones P. A. Multiple new phenotypes induced in 10T1/2 3T3 cells treated with 5-azacytidine. Cell 1979; 17: 771 – 179
22. Baylin S. B., Makos M., Wu J., Yen R. W. C., de Bustros A., Vertino P., Nelkin B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 1991; 3: 383 – 390
23. De Simone J., Heller P., Hall L., Zwiers D. 5-azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Natl. Acad. Sci. (USA) 1982; 79: 4428 – 4431
24. Charache S., Dover G., Smith K., Talhot C. C., Moyer M., Boyer S. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal haemoglobin products and is associated with non-random hypomethylation of DNA around the γ-α-β-globin gene complex. Proc. Natl. Acad. Sci. (USA). 1983; 80: 4842 – 4846
25. Gama-Sosa M. A., Slagel V. A., Trewyn R. W., Oxenhandler R., Kuo K. C., Gehrke C. W., Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucl. Acids Rex 1983; 11: 6883 – 6894
26. Laird P. W., Jackson-Grusby L., Fazell A., Dickinson S. L., Jung W. E., Li E., Weinberg R. A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197 – 205
27. El-Deiry W. S., Nelkin B. D., Celano P., Yen R. -W. C., Falco J. P., Hamilton S. R., Baylin S. B. High expression of the methyltransferase gene characterises human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. (USA). 1991; 88: 3470 – 3474
28. MacLeod A. R., Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Bid. Chern. 1995; 270: 80377 – 8043
29. Ohtani-Fujita N., Fujita T., Aoike A., Osifchin N. E., Robbins P. D., Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene. 1993; 8: 1063 – 1067
30. Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S. R., Gnarra J. R., Linehan W. M., Baylin S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 1994; 91: 9700 – 9704
31. Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C., Baylin S. B., Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/cDKN2/MTS1 in human cancers. Nature Med. 1995; 1: 686 – 692
32. Braun T., Bober E., Buschhausen-Denker G., Kotz S., Grzeschik K. H., Arnold H. H. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the M f gene products. EMBO J. 1989; 8: 3617 – 3625
33. Kay P. H., Taylor J., Kees U. R., Baker D. L., Spagnolo D. Myf-3 hypermethylation in malignant lymphoproliferative disorders. Br. J. Cancer. 1995; 62: 797 – 799
34. Jones P. A., Wolkowicz M. J., Hanington M. A., Gonzalez F. Methylation and expression of the Myo-D1 determination gene. Philos. Trans, R. Soc. London 1990; 326: 277 – 284
35. Davis R. L., Weintraub H., Lassar A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987 – 1000
36. Jones P. A., Wolkowicz M. J., Rideout W. M., III, Gonzales F. A., Marziasz G. A., Coetzee G. A., Tapscott S. J. De novo methylation of the MyoDl CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. (USA) 1990; 87: 6117 – 21
37. Song K., Yaoqi W., Sassoon D. Expression of Hox-7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 1992; 360: 477 – 481
38. Sorrentino V. R., Peperkok R., Davis R. L., Ansorge W., Philipson L. Cell proliferation inhibited by MyoD. Nature 1990; 345: 813 – 815
39. Crescenzi M., Fleming T. P., Lassar A. B., Weintraub H., Aaronson S. A. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. (USA) 1990; 87: 8442 – 8446
40. Halevy O., Novitch B. G., Spicer D. B., Skapek S. X., Rhee J., Hannon G. J., Berach D., Lassar A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018 – 1021
41. Tapscott S. J., Davis R. L., Thayer M. I., Cheng P. -F., Weintraub H., Lassar A. B. Myo-DI: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988; 242: 405 – 411
42. Beuche M., Senni M. I., Grossi A. M., Zappelli F., Polimeni M., Arnold H. H., Cossu G., Molinaro M. TPA-induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp. Cell Rex 1993; 208: 205 – 217
43. Stoye J. P., Moroni C., Coffin J. M. Virological events leading to spontaneous AKR thymomas. J. Virol. 1991; 65: 1273 – 1285
44. Kay P. H., Jacobsen P. F., Taylor J., Spagnolo D. The significance of DNA methylation in Cancer. Adv. Anat. Path. 1995; 2: 353 – 361
45. Adams B., Dorfler P., Aguzzi A., Koznik Z., Urbanck P., Maurer-Fogy I., Busslinger M. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992; 6: 1589 – 1607
46. Maulbecker C. C., Gruss P. The oncogenic potential of Pax genes. EMBO J. 1993; 12: 2361 – 2367
47. Tsukamoto K., Nakamura Y., Niikawa N. Isolation of two isoforms of the PAX3 transcripts and their tissue specific abberative expression in human adult tissues. Genet. 1994; 93: 270 – 274
48. Schafer B. W., Czerny T., Bernasconi M., Genini M., Busslinger M. Molecular cloning and characterisation of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucl. Acids Res. 1994; 22: 4574 – 4582
49. Goulding M., Chalepakis G., Deutsch V., Erselius J. R., Gnss P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 1991; 10: 1135 – 1147
50. Goulding M., Paquette A. Neural Tube Defects. Ciba Foundation Symposium 181, Wiley, Chichester 1994; 103 – 117
51. Kioussi C., Gross M. K., Gruss P. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron. 1995; 15: 553 – 562
52. Chalepakis G., Jones F. S., Edelman G. M., Gnss P. Pax-3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA 1994; 91: 12745 – 12749
53. Stuart E. T., Kioussi C., Gruss P. Mammalian PAX genes. Annu. Rev. Genet. 1993; 27: 219 – 236
54. Epstein D. J., Vekemans M., Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within a paired homeodomain of Pax-3. Cell 1991; 67: 767 – 774
55. Bober E., Franz T., Arnold H. H., Gnss P., Tremblay P. Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 1994; 120: 603 – 612
56. Jostes B., Walther C., Gruss P. The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 1991; 33: 27 – 38
57. Yaffe D., Saxel D. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725 – 727
58. Spagnolo D. V., Taylor J., Carrello S., Saueracker E., Kay P. H. Southern blot analysis of lymphoproliferative disorders: use and limitations in routine surgical pathology. Pathology 1994; 26: 268 – 275